Delivery included to the United States

Targeting the Wnt Pathway in Cancer

Targeting the Wnt Pathway in Cancer

2011

Paperback (13 Oct 2014)

  • $185.65
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of -catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway.

Book information

ISBN: 9781489981646
Publisher: Springer New York
Imprint: Springer
Pub date:
Edition: 2011
Language: English
Number of pages: 240
Weight: 391g
Height: 235mm
Width: 155mm
Spine width: 13mm